Detection and quantitation of human papillomavirus by using the fluorescent 5′ exonuclease assay

被引:66
作者
Josefsson, A
Livak, K
Gyllensten, U
机构
[1] Univ Uppsala, Dept Genet & Pathol, Unit Med Genet, S-75123 Uppsala, Sweden
[2] Perkin Elmer Inc, Appl Biosyst Div, Foster City, CA USA
关键词
D O I
10.1128/JCM.37.3.490-496.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A method for the detection and quantitation of oncogenic human papillomavirus (I-IPV) was developed by using the fluorescent 5' exonuclease assay. The method is based on the amplification of a 180-bp fragment from the 3' part of the El open reading frame in a single PCR with type-specific probes for I IPV tapes 16, 18, 31, 33, and 35, The probes can be used separately or in combinations of up to three probes per assay. Quantitation over a range of 10(1) to 10(6) initial HPV copies was possible by using real-time detection of the accumulation of fluorescence with cycle number. Reconstitution experiments, performed to mimic mired infections, showed that individual HPV types can be detected down to a ratio of about 1% in a mixture, The performance of the assay depends on DNA quality, the presence of PCR inhibitors, and the number of different probes used simultaneously. This homogeneous assay provides a fast and sensitive way of screening for oncogenic HPV types in biopsy specimens as well as cervical smear samples. The closed-tube nature of the assay and the inclusion of uracil N'-glycosylase reduces cross contamination of PCR products to a minimum. A similar assay for p-actin was used in parallel for quantitation of genomic DNA. After normalizing the samples for genomic DNA content, the mean number of HPV copies per cell could be calculated.
引用
收藏
页码:490 / 496
页数:7
相关论文
共 37 条
[1]   A NOVEL TYPE OF HUMAN PAPILLOMAVIRUS ASSOCIATED WITH GENITAL NEOPLASIAS [J].
BEAUDENON, S ;
KREMSDORF, D ;
CROISSANT, O ;
JABLONSKA, S ;
WAINHOBSON, S ;
ORTH, G .
NATURE, 1986, 321 (6067) :246-249
[2]  
BONNEZ W, 1993, CLIN INFECT DIS, V17, P1080, DOI 10.1093/clinids/17.6.1080
[3]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[4]   ANALYSIS OF HUMAN PAPILLOMAVIRUS TYPES IN EXOPHYTIC CONDYLOMATA ACUMINATA BY HYBRID CAPTURE AND SOUTHERN BLOT TECHNIQUES [J].
BROWN, DR ;
BRYAN, JT ;
CRAMER, H ;
FIFE, KH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (10) :2667-2673
[5]   The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women [J].
Carter, JJ ;
Koutsky, LA ;
Wipf, GC ;
Christensen, ND ;
Lee, SK ;
Kuypers, J ;
Kiviat, N ;
Galloway, DA .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (05) :927-936
[6]  
CHARDONNET Y, 1992, CYTOPATHOLOGY, V3, P341
[7]  
CHUA KL, 1995, ANAL QUANT CYTOL, V17, P221
[8]  
de Villiers E M, 1994, Curr Top Microbiol Immunol, V186, P1
[9]  
de Villiers E M, 1992, IARC Sci Publ, P111
[10]   HETEROGENEITY OF THE HUMAN PAPILLOMAVIRUS GROUP [J].
DEVILLIERS, EM .
JOURNAL OF VIROLOGY, 1989, 63 (11) :4898-4903